Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B vaccine immunogenicity and reactogenicity in incarcerated adult men
RBR-27bn6zCompleted
- Sponsor
- Faculdade de Enfermagem da Universidade Federal de Goiás
- Start
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Hepatitis B vaccine and hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by Faculdade de Enfermagem da Universidade Federal de Goiás. Primary endpoints: Immunogenicity and Reactogenicity. Started Oct 2017; status: completed.
02
Drugs
Hepatitis B vaccinehepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on RBR-27bn6z.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-27bn6z.